ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 746351 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 746351; 2) Community: the network communities that were significantly associated with the response to NSC 746351; 3) Molecule: the relationships between components within communities and NSC 746351; 4) MDR: the compounds that were significantly associated with the NSC 746351.

NSC Compound Enrichment Correlation
NSC 624872 Null 0.0385613993886001 0.28052187
NSC 627506 Null 0.0385613993886001 0.30501825
NSC 633268 Null 0.0385613993886001 0.26840642
NSC 637130 Null 0.0385613993886001 0.43630311
NSC 638635 Propyl-1-aminium, 3-[3,5-bis(phenylmethylene)-4-oxo- piperidin-1-yl]-3-oxo-N,N,N-trimethyl-, bromide 0.0385613993886001 0.4595289
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0385613993886001 0.2978283
NSC 644919 Null 0.0385613993886001 0.48892972
NSC 654378 Null 0.0385613993886001 0.25135634
NSC 654509 Pirarubicin HCl 0.0385613993886001 0.55259933
NSC 65628 Null 0.0385613993886001 0.5324189
Total:78  Current:62    [First] [Prev] [Next] [Last]